D is strictly regulated and independent of circulating 25(OH)D, rarely differs from normal and only requires measurement upon suspicion of specific conditions [1] . On the other hand, the amount of the hormonally inactive metabolite 24,25(OH) 2 D is dependent on the amount of its predecessor 25(OH)D and the activity of the enzyme responsible for its production. The ratio of 24,25(OH) 2 D over 25(OH)D is thus indicative for the efficiency of this catabolic clearance by CYP24A1. As such, it can be used to identify disorders caused by enzyme malfunctioning, such as the rare genetic disorder idiopathic infantile hypercalcaemia (IIH). At the heart of this condition is an inactivating mutation in CYP24A1, almost completely preventing the inactivation of the active hormone, resulting in the overproduction of 1,25(OH) 2 D and severe hypercalcaemia [2] . IIH patients present with severely increased 25(OH)D/24,25(OH) 2 [7] . After measurement of SRM 972a and DEQAS samples 446-450 (with a NIST target value) we found a bias of +24% for our method. We have therefore recalculated the earlier obtained reference values for 24,25(OH) 2 (Table 2) .
Two earlier publications reported similar results (Table 2) . Tang et al. determined a reference interval in a population consisting of mainly younger men (all below 32 years of age) [8] . Like us, they chose not to exclude the vitamin D deficient individuals from the reference group. Ketha et al., on the other hand, only included vitamin D-sufficient individuals [3] . We decided to include the apparently healthy individuals with low 25(OH)D levels to avoid omitting a large part of the world's population. Many of the patients we measure in the clinic may be considered vitamin D deficient or insufficient but have a perfectly functioning CYP24A1 enzyme and therefore a healthy 25(OH)D/24,25(OH) 2 
